Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quality of life issues in patients with inflammatory bowel disease.
Irvine EJ. Irvine EJ. Am J Gastroenterol. 1997 Dec;92(12 Suppl):18S-24S. Am J Gastroenterol. 1997. PMID: 9395348 Review.
Quality of life in patients with immune-mediated inflammatory diseases.
Russell AS, Gulliver WP, Irvine EJ, Albani S, Dutz JP. Russell AS, et al. Among authors: irvine ej. J Rheumatol Suppl. 2011 Nov;88:7-19. doi: 10.3899/jrheum.110899. J Rheumatol Suppl. 2011. PMID: 22045973 Review.
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ. Marshall JK, et al. Among authors: irvine ej. Cochrane Database Syst Rev. 2012 Nov 14;11:CD004118. doi: 10.1002/14651858.CD004118.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152224 Review.
Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ. Marshall JK, et al. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004115. doi: 10.1002/14651858.CD004115.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091560 Review.
Prospective comparison of small bowel meal with pneumocolon versus ileo-colonoscopy for the diagnosis of ileal Crohn's disease.
Marshall JK, Cawdron R, Zealley I, Riddell RH, Somers S, Irvine EJ. Marshall JK, et al. Am J Gastroenterol. 2004 Jul;99(7):1321-9. doi: 10.1111/j.1572-0241.2004.30499.x. Am J Gastroenterol. 2004. PMID: 15233672
Patient outcomes after anti TNF-alpha drugs for Crohn's disease.
Assasi N, Blackhouse G, Xie F, Marshall JK, Irvine EJ, Gaebel K, Robertson D, Campbell K, Hopkins R, Goeree R. Assasi N, et al. Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):163-75. doi: 10.1586/erp.10.13. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20384563 Review.
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease.
Blackhouse G, Assasi N, Xie F, Marshall J, Irvine EJ, Gaebel K, Campbell K, Hopkins R, O'Reilly D, Tarride JE, Goeree R. Blackhouse G, et al. Among authors: irvine ej. J Crohns Colitis. 2012 Feb;6(1):77-85. doi: 10.1016/j.crohns.2011.07.007. Epub 2011 Sep 9. J Crohns Colitis. 2012. PMID: 22261531
Measurement and expression of risk: optimizing decision strategies.
Irvine EJ. Irvine EJ. Am J Med. 2004 Sep 6;117 Suppl 5A:2S-7S. doi: 10.1016/j.amjmed.2004.07.029. Am J Med. 2004. PMID: 15478846 Review.
83 results
Jump to page
Feedback